Illumina Files Two Patent Infringement Suits
The suits involve the use of cell-free fetal DNA for noninvasive prenatal testing.
Read MorePosted by Elaine Sanchez Wilson | Jan 18, 2016 | Uncategorized |
The suits involve the use of cell-free fetal DNA for noninvasive prenatal testing.
Read MorePosted by Elaine Sanchez Wilson | Jan 18, 2016 | Molecular Diagnostics |
The Progensa prostate cancer antigen 3 assay can help improve prediction of repeat biopsy outcomes in men who have had one or more prior negative prostate biopsies.
Read MorePosted by Elaine Sanchez Wilson | Jan 7, 2016 | Disease States |
In recent years, populations in a number of regions throughout the world have found themselves at ground zero for an increasing variety of previously unknown infectious and zoonotic diseases.
Read MorePosted by Elaine Sanchez Wilson | Jan 5, 2016 | Molecular Diagnostics |
Nanosphere reports that its FDA-cleared Verigene Gram-negative blood culture test can identify the antibiotic resistance gene associated with the emerging “phantom menace” superbug.
Read MorePosted by Elaine Sanchez Wilson | Jan 4, 2016 | Molecular Diagnostics |
At the 2015 San Antonio Breast Cancer Symposium, held last December in San Antonio, Texas, basic researchers and clinicians shared state-of-the art information on breast cancer research.
Read More